Articles

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia

Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Institute of Hematology and Blood Transfusion, Prague, Czech Republic;Institute of Pathological Physiology, First Medical Faculty, Charles University, Prague, Czech Republic
Institute of Hematology and Blood Transfusion, Prague, Czech Republic;Institute of Pathological Physiology, First Medical Faculty, Charles University, Prague, Czech Republic
Institute of Pathological Physiology, First Medical Faculty, Charles University, Prague, Czech Republic
Department of Medicine, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore, MD, USA
Department of Microbiology and Immunology, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore, MD, USA
Institute of Hematology and Blood Transfusion, Prague, Czech Republic;Institute of Clinical and Experimental Hematology, First Medical Faculty, Charles University, Prague, Czech Republic
Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Institute of Hematology and Blood Transfusion, Prague, Czech Republic
Institute of Hematology and Blood Transfusion, Prague, Czech Republic
BIOCEV, First Medical Faculty, Charles University, Vestec, Czech Republic
Department of Medicine, Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore, MD, USA
Institute of Hematology and Blood Transfusion, Prague, Czech Republic;Institute of Clinical and Experimental Hematology, First Medical Faculty, Charles University, Prague, Czech Republic
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.193086